Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype.

MLA

Cooper-Knock, Johnathan, et al. “Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype.” Frontiers in Molecular Neuroscience, Nov. 2017, pp. 1–11. EBSCOhost, https://doi.org/10.3389/fnmol.2017.00370.

APA

Cooper-Knock, J., Robins, H., Niedermoser, I., Wyles, M., Heath, P. R., Higginbottom, A., Walsh, T., Kazoka, M., Ince, P. G., Hautbergue, G. M., McDermott, C. J., Kirby, J., & Shaw, P. J. (2017). Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype. Frontiers in Molecular Neuroscience, 1–11. https://doi.org/10.3389/fnmol.2017.00370

Chicago

Cooper-Knock, Johnathan, Henry Robins, Isabell Niedermoser, Matthew Wyles, Paul R. Heath, Adrian Higginbottom, Theresa Walsh, et al. 2017. “Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype.” Frontiers in Molecular Neuroscience, November, 1–11. doi:10.3389/fnmol.2017.00370.